BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu M, Liu X, Ye Y, Yan X, Cheng Y, Zhao L, Chen F, Ling Z. Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease. Front Immunol 2022;13:937555. [DOI: 10.3389/fimmu.2022.937555] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Bashir Y, Khan AU. The interplay between the gut-brain axis and the microbiome: A perspective on psychiatric and neurodegenerative disorders. Front Neurosci 2022;16. [DOI: 10.3389/fnins.2022.1030694] [Reference Citation Analysis]
2 Araújo B, Caridade-Silva R, Soares-Guedes C, Martins-Macedo J, Gomes ED, Monteiro S, Teixeira FG. Neuroinflammation and Parkinson's Disease-From Neurodegeneration to Therapeutic Opportunities. Cells 2022;11:2908. [PMID: 36139483 DOI: 10.3390/cells11182908] [Reference Citation Analysis]
3 Hong H, Sloan L, Saxena D, Scott DA. The Antimicrobial Properties of Cannabis and Cannabis-Derived Compounds and Relevance to CB2-Targeted Neurodegenerative Therapeutics. Biomedicines 2022;10:1959. [DOI: 10.3390/biomedicines10081959] [Reference Citation Analysis]